Equities

Fuse Medical Inc

FZMD:PKL

Fuse Medical Inc

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)0.0741
  • Today's Change0.00 / 0.00%
  • Shares traded10.09k
  • 1 Year change+23.50%
  • Beta-0.9380
Data delayed at least 15 minutes, as of Jun 10 2024 20:11 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fuse Medical, Inc. is a manufacturer and distributor of medical devices in the United States. The Company provides a range of a portfolio of orthopedic implants, including foot and ankle, orthopedics, sports medicine and spine. It also provides a range of osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. Its foot and ankle product offerings include internal and external fixation for forefoot, midfoot and hindfoot reconstruction. Its orthopedics offer joint reconstruction systems for upper and lower extremities, which include the sterizo total knee, tibial revision, and total hip replacement systems, as well as the arrow total and reverse total shoulder system. Its sports medicine offers a line of fuse suture anchors and interference screws, as well as multiple products for soft tissue fixation augmentation. Its spine offers spinal products for cervical and thoracolumbar fusion.

  • Revenue in USD (TTM)18.40m
  • Net income in USD3.63m
  • Incorporated1999
  • Employees31.00
  • Location
    Fuse Medical Inc1565 North Central Expressway, Suite 220RICHARDSON 75080United StatesUSA
  • Phone+1 (469) 862-3030
  • Fax+1 (302) 655-5049
  • Websitehttps://fusemedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ReShape Lifesciences Inc8.34m-10.92m4.59m31.00--1.01--0.551-2.30-2.300.73190.19330.67810.81784.52268,871.00-88.83-136.06-162.20-194.3265.8556.30-130.99-408.361.26--0.00---22.79-0.947475.36---49.29--
BIOLASE Inc48.83m-38.26m4.80m157.00------0.0982-20.50-20.508.640.00811.282.219.00311,006.40-55.75-49.28-118.58-85.8034.2535.27-43.56-50.720.6409-5.980.9812--1.451.27-30.39--18.63--
Arch Therapeutics Inc130.55k-8.43m4.87m8.00------37.28-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
Encision Inc6.87m-448.00k4.94m31.00--2.25--0.7198-0.0381-0.03810.58350.18631.641.967.84221,520.00-10.69-1.07-14.05-1.4650.5452.27-6.52-0.6131.08-6.220.1123---4.17-3.44-393.90--12.89--
Predictive Oncology Inc1.96m-14.78m5.00m34.00--1.22--2.55-3.66-3.660.48530.99770.10991.714.9557,642.65-82.89-91.80-108.54-126.2964.1864.64-754.19-1,419.991.35--0.0093--18.244.7545.67--5.44--
Nu-Med Plus Inc0.00-119.16k5.01m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
Vapotherm Inc70.07m-54.94m5.10m182.00------0.0727-8.62-8.6211.00-11.020.81221.467.53385,011.00-63.68-49.73-587.27-62.5445.2843.56-78.40-78.990.1259-1.272.59--2.8010.1448.62---10.38--
Pressure Biosciences Inc1.98m-35.20m5.19m15.00------2.62-1.65-1.650.0885-0.92611.292.388.86131,850.70-1,916.46-872.30----40.4332.33-1,482.20-1,066.480.0136-0.595----14.37-4.25-97.72------
ADM Tronics Unlimited Inc2.85m-716.86k5.39m7.00--4.89--1.90-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Sharps Technology Inc0.00-8.71m5.40m3.00--0.7864-----0.6204-0.62040.000.43780.00-------74.67---95.84----------0.492--0.00-------112.12------
Fuse Medical Inc18.40m3.63m5.48m31.002.06--1.480.29750.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Venus Concept Inc73.30m-37.39m5.95m304.00------0.0812-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
BioSig Technologies Inc27.00k-25.25m6.35m4.00------235.32-3.24-3.240.0033-0.37760.008--1.746,750.00-728.65-269.73---363.1148.15---91,566.66-24,485.73---------93.71---6.52---9.58--
Sigyn Therapeutics Inc0.00-3.56m6.43m5.00---------3.04-3.040.00-3.280.00----0.00-724.37-493.15-----------10,223.960.0199-1.92---------41.51------
Sonendo Inc40.19m-57.74m6.69m216.00--0.2725--0.1664-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Nexalin Technology Inc158.86k-4.94m6.69m6.00--2.87--42.09-0.6676-0.66760.02150.31290.03630.177844.0126,476.67-112.76---139.94--82.54---3,110.58--4.75--0.00---91.62---173.80------
Data as of Jun 10 2024. Currency figures normalised to Fuse Medical Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.